picibanil has been researched along with Blepharoptosis* in 2 studies
1 review(s) available for picibanil and Blepharoptosis
Article | Year |
---|---|
Periorbital lymphatic malformation: clinical course and management in 42 patients.
Lymphatic malformation in the orbital cavity and surrounding region often causes disfigurement and visual problems. To better clarify the evolution and treatment of this condition, the authors studied a retrospective cohort of 42 consecutive patients seen between 1971 and 2003 and analyzed anatomic features, complications, and management. The ratio of female to male patients was 1:1. Most periorbital lymphatic malformations were noted at birth (59 percent), presenting as either unilateral swelling (60 percent) or a periorbital mass (24 percent). Sixty-two percent of lesions were on the left side. The ipsilateral cheek, temple, and forehead also were involved in 57 percent of patients. Twenty-two percent of lesions were intraconal, 30 percent were extraconal, and 48 percent were in both spaces. Forty-five percent of children had an associated cerebral developmental venous anomaly. Periorbital lymphatic malformation caused major morbidity; 52 percent of patients had intralesional bleeding and 26 percent of patients had a history of infection. Other common complications included intermittent swelling (76 percent), blepharoptosis (52 percent), proptosis (45 percent), pain (21 percent), amblyopia (33 percent), chemosis (19 percent), astigmatism (17 percent), and strabismus (7 percent). Ultimately, 40 percent of children had diminished vision and 7 percent became blind in the affected eye. Management of periorbital lymphatic malformation involved an interdisciplinary team that included an interventional radiologist, a craniofacial surgeon, and an ophthalmologist. The two therapeutic strategies were sclerotherapy (40 percent) and resection (57 percent); most patients required several interventions. A coronal approach was used for subtotal excision of fronto-temporal-orbital lymphatic malformation in 13 patients, whereas a tarsal incision was used for lesions isolated to the eyelid (n = 14). Ocular proptosis was temporarily managed by tarsorrhaphy (n = 9), but expansion of the bony orbit was needed to correct persistent proptosis (n = 8). Orbital exenteration was necessary in two patients. Topics: Abnormalities, Multiple; Adolescent; Adult; Blepharoptosis; Blindness; Cerebral Veins; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Edema; Exophthalmos; Eye Infections; Face; Female; Hemorrhage; Humans; Infant; Infant, Newborn; Lymphatic Abnormalities; Male; Orbit; Picibanil; Plastic Surgery Procedures; Retrospective Studies; Sclerotherapy; Vision Disorders | 2005 |
1 other study(ies) available for picibanil and Blepharoptosis
Article | Year |
---|---|
[Unsuccessful treatment with OK-432 picibanil for orbital lymphangioma].
Lymphangioma is a malformation of the lymphatic system. The classic approach is surgery. We report a case of orbital lymphangioma in a girl who was given OK-432 to avoid surgery and its complications.. OK-432 is a lyophilized mixture of group A Streptococcus pyogenes which produces a fibrosis limited to the lesion with a high cure rate. The main advantages are the easy intra-lesional application. with no scars and or damage of closed areas. Its main disadvantage is a significant local inflammatory reaction. Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents; Blepharoptosis; Eyelid Diseases; Female; Hematoma; Humans; Lymphangioma; Magnetic Resonance Imaging; Orbital Neoplasms; Picibanil; Sclerosing Solutions; Treatment Failure | 2012 |